Pioneering genetic cures
Sangamo is committed to translating ground-breaking gene-editing science into genomic therapies that transform patients’ lives. Sangamo engaged HDMZ to reinvigorate their brand and expand their presence within the science world. HDMZ crafted a brand platform, new corporate identity featuring a new logo, website with refined messaging, and clinical trial branding support. HDMZ also designed a PR strategy to increase Sangamo's share of voice within the genome editing and drug development communities.